Fatty liver disease and sleep apnea study
Part of Brain & nervous system, Lungs & breathing clinical trials.
This study looks at the link between fatty liver disease and obstructive sleep apnea. It may help understand if one condition affects the other.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over 18 years old
- You have symptoms like snoring, daytime sleepiness, or someone has witnessed you stop breathing during sleep
- You do not have cancer
- You do not have type 1 diabetes
- You have not had weight loss surgery for fatty liver
- You do not have certain other sleep disorders or lung diseases with low oxygen
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a simple walking program can help people who have both obstructive sleep apnea and non-alcoholic fatty liver disease. If you have these conditions and a BMI under 35, you may be able to join a free exercise program to see if it improves your health.
This study tests a sleep apnea treatment approach and looks at how it may affect your body’s metabolism. You may be eligible if you’re an adult with sleep apnea and meet health and medication rules, and possibly if you already use a PAP machine regularly.
This study looks at people with mild to moderate obstructive sleep apnea (OSA) to understand how inflammation and breathing disruption may affect future heart and metabolism risk. It may help explain why some people develop higher risk even with milder sleep apnea.
This study looks at people who may have obstructive sleep apnea, a breathing problem during sleep. It aims to better understand the condition in Hong Kong and what to do next for diagnosis or care.
This trial looks at how obstructive sleep apnea (OSA, a breathing problem during sleep) relates to heart outcomes in people with atrial fibrillation (AF). It may help doctors better predict risk and choose safer care for people who are high cardiovascular risk.
This study classifies fatty liver disease (MAFLD) by examining liver tissue samples. It aims to better understand how metabolic risk factors like high blood sugar, high blood pressure, or excess weight relate to the liver's condition.
Hear when a new Obstructive Sleep Apnea trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.